allergic conjunctivitis
Showing 51 - 75 of 121
Allergic Conjunctivitis, Allergic Rhinitis Trial in Andover (Dose Level 1, Dose Level 2, Placebo)
Terminated
- Allergic Conjunctivitis
- Allergic Rhinitis
- Dose Level 1
- +2 more
-
Andover, MassachusettsAndover Eye Associates
Feb 21, 2018
Allergic Conjunctivitis Trial (Olopatadine Hydrochloride Ophthalmic Solution 0.2%, Olopatadine Hydrochloride Ophthalmic Solution
Completed
- Allergic Conjunctivitis
- Olopatadine Hydrochloride Ophthalmic Solution 0.2%
- +2 more
- (no location specified)
Oct 17, 2017
Allergic Conjunctivitis Trial in Andover (AC-170 0.24%, AC-170 0%)
Completed
- Allergic Conjunctivitis
- AC-170 0.24%
- AC-170 0%
-
Andover, MassachusettsOra, Inc.
Oct 11, 2017
Allergic Conjunctivitis Trial in Andover (AC-170 0.24%, AC-170 0%)
Completed
- Allergic Conjunctivitis
- AC-170 0.24%
- AC-170 0%
-
Andover, MassachusettsOra, Inc.
Oct 6, 2017
Allergic Conjunctivitis Trial in Andover (AC-170 0.24%, AC-170 0%)
Completed
- Allergic Conjunctivitis
- AC-170 0.24%
- AC-170 0%
-
Andover, MassachusettsAndover Eye Associates
Sep 11, 2017
Allergic Conjunctivitis Trial in Andover (AC-150 Combo, AC-150A 0.1%, AC-150B 0.005%)
Completed
- Allergic Conjunctivitis
- AC-150 Combo
- +3 more
-
Andover, MassachusettsOra, Inc
Sep 13, 2017
Allergic Conjunctivitis Trial in Andover (AC-170 0.05%, AC-170 0.1%, AC-170 0.24%)
Completed
- Allergic Conjunctivitis
- AC-170 0.05%
- +3 more
-
Andover, MassachusettsOra, Inc.
Jul 31, 2017
Allergic Conjunctivitis Trial in Lexington (hydrocortisone ophthalmic ointment 0.5%, )
Terminated
- Allergic Conjunctivitis
- hydrocortisone ophthalmic ointment 0.5%
- placebo
-
Lexington, KentuckyKoffler Vision Group
Aug 15, 2017
Allergic Conjunctivitis Trial (Olopatadine Hydrochloride Ophthalmic Solution, 0.2%, Olopatadine Hydrochloride Ophthalmic
Completed
- Allergic Conjunctivitis
- Olopatadine Hydrochloride Ophthalmic Solution, 0.2%
- Olopatadine Hydrochloride Ophthalmic Solution Vehicle
- (no location specified)
Aug 10, 2017
Allergic Rhinitis, Allergic Conjunctivitis Trial in Nashville (olopatadine, )
Completed
- Allergic Rhinitis
- Allergic Conjunctivitis
- olopatadine
- placebo
-
Nashville, TennesseeVanderbilt Asthma, Sinus and Allergy Program Research
Jun 12, 2017
Allergic Rhinitis, Allergic Conjunctivitis, Atopic Dermatitis Trial in Baltimore (XmAb7195, Placebo)
Completed
- Allergic Rhinitis
- +2 more
- XmAb7195
- Placebo
-
Baltimore, MarylandParexel Baltimore Early Phase Clinical Unit
Jan 23, 2017
Allergic Conjunctivitis Trial in Padova (Olopatadine (generic name))
Completed
- Allergic Conjunctivitis
- Olopatadine (generic name)
-
Padova, ItalyPadova Site
Nov 18, 2016
Allergic Conjunctivitis Trial in Andover (SPARC1102 I, SPARC1102 II, SPARC1102 III)
Completed
- Allergic Conjunctivitis
- SPARC1102 I
- +3 more
-
Andover, MassachusettsORA Inc
May 23, 2016
Eye Allergies and Determining if There Are Also Dry Eyes
Completed
- Dry Eyes
- Allergic Conjunctivitis
-
Scottsdale, ArizonaSchwartz Laser Eye Center
Jun 2, 2016
Allergic Conjunctivitis, Seasonal Allergies Trial in Mississauga (NS2 Ophthalmic Drops (0.5%), NS2 Ophthalmic Drops Vehicle
Completed
- Allergic Conjunctivitis
- Seasonal Allergies
- NS2 Ophthalmic Drops (0.5%)
- NS2 Ophthalmic Drops Vehicle (0.0%)
-
Mississauga, Ontario, CanadaInflamax Research Inc.
May 25, 2016
A Patient Reported Ocular Comfort Assessment Comparing Bepreve
Completed
- Allergic Conjunctivitis
-
Austin, TexasDerek Cunningham
Jan 26, 2016
Allergic Rhinitis, Allergic Conjunctivitis Trial in Hamburg (modified allergen extract, Placebo)
Unknown status
- Allergic Rhinitis
- Allergic Conjunctivitis
- modified allergen extract
- Placebo
-
Hamburg, Germany(unnamed)
Nov 2, 2015
Allergic Conjunctivitis Trial (Olopatadine HCl ophthalmic solution, 0.1%, Epinastine HCl ophthalmic solution, 0.05%)
Completed
- Allergic Conjunctivitis
- Olopatadine HCl ophthalmic solution, 0.1%
- Epinastine HCl ophthalmic solution, 0.05%
- (no location specified)
Oct 5, 2015
The Significance of Ambrosia in Allergic Rhinitis and Asthma in
Completed
- Allergic Rhinitis
- +3 more
-
Kfar-Saba, IsraelArnon Goldberg, M.D., Allergy and Clinical Immunology Unit, Meir
Oct 6, 2015
Allergic Conjunctivitis Trial (AL-53817 Ophthalmic Solution, 0.1%, AL-78843 Ophthalmic Solution, 0.03%, Dexamethasone Ophthalmic
Completed
- Allergic Conjunctivitis
- AL-53817 Ophthalmic Solution, 0.1%
- +3 more
- (no location specified)
Aug 7, 2015
Allergic Conjunctivitis Trial in Tokyo (Olopatadine HCl ophthalmic solution 0.1%)
Completed
- Allergic Conjunctivitis
- Olopatadine hydrochloride ophthalmic solution 0.1%
-
Tokyo, JapanContact Alcon Call Center For Trial Locations
May 11, 2015
Allergic Conjunctivitis Trial in Gardena, North Andover, Memphis (K-Lens (generic name not established) and Ketotifen, Placebo
Completed
- Allergic Conjunctivitis
- K-Lens (generic name not established) and Ketotifen
- Placebo Lens
-
Gardena, California
- +2 more
Feb 18, 2015
Allergic Conjunctivitis Trial in Fairfield, Mason (alcaftadine, Placebo)
Allergic Conjunctivitis Trial in Memphis (contact lens with ketotifen, contact lens)
Completed
- Allergic Conjunctivitis
- contact lens with ketotifen
- contact lens
-
Memphis, Tennessee(unnamed)
Feb 18, 2015